Sugarfit shows up in
33%
Sugarfit appears in 0% of buyer questions and 100% of direct comparison questions that include Sugarfit. mfine appears in 33% of buyer questions.
AI search report
See where Sugarfit is losing buyers in AI search
See when AI mentions Sugarfit, where buyer questions leave you out, and what to fix first so more buyers discover you before competitors.
What buyers see in AI search
What AI says before buyers reach Sugarfit's site
Buyer questions missed
67%
Sugarfit is left out of 67% of the buyer and comparison questions checked.
Who AI recommends instead
mfine
mfine is the competitor AI surfaces most often here.
Where AI already picks you
AI does not consistently connect Sugarfit with a clear reason buyers would choose it yet. That usually means the evidence buyers need is either missing, scattered, or easier to find on competitor sites.
Where competitors beat you
- Competitors beat Sugarfit on Blood Sugar Tracking. Practo is rated moderate while Sugarfit is limited.
- Competitors beat Sugarfit on Doctor Consultations. Lybrate is rated moderate while Sugarfit is limited.
- Competitors beat Sugarfit on Endocrinologist Access. Lybrate is rated moderate while Sugarfit is limited.
How AI describes you vs competitors
What AI connects each brand with
| What buyers care about | What this means | Sugarfit | Practo | mfine | Lybrate |
|---|---|---|---|---|---|
| Blood Sugar Tracking | AI gives Practo more credit for blood sugar tracking than Sugarfit. | Barely associated | Sometimes associated | Barely associated | Barely associated |
| Glucose Monitoring | AI gives mfine more credit for glucose monitoring than Sugarfit. | Barely associated | Barely associated | Sometimes associated | Barely associated |
| Medication Reminders | AI has little clear evidence connecting Sugarfit with medication reminders. | Barely associated | Barely associated | Barely associated | Barely associated |
| Telemedicine Consultations | AI gives mfine more credit for telemedicine consultations than Sugarfit. | Barely associated | Barely associated | Clearly associated | Barely associated |
| Doctor Consultations | AI gives Lybrate more credit for doctor consultations than Sugarfit. | Barely associated | Barely associated | Barely associated | Sometimes associated |
| Endocrinologist Access | AI gives Lybrate more credit for endocrinologist access than Sugarfit. | Barely associated | Barely associated | Barely associated | Sometimes associated |
Buyer questions you are missing
The questions where buyers may never see Sugarfit
These are high-intent questions where AI did not mention Sugarfit. Each one can become a clear answer page AI can trust and reuse, supported by evidence from Sugarfit's site.
Buyer question
best diabetes management app with doctor consultation in India
Sugarfit was not mentioned in this AI answer.
See the AI answerBuyer question
online blood sugar monitoring platform with telemedicine support
Sugarfit was not mentioned in this AI answer.
See the AI answerBuyer question
affordable diabetes control subscription service with nutritionist guidance
Sugarfit was not mentioned in this AI answer.
See the AI answerBuyer question
how to manage type 2 diabetes and weight loss together online
Sugarfit was not mentioned in this AI answer.
See the AI answerBuyer question
real-time glucose tracking app with virtual doctor appointments India
Sugarfit was not mentioned in this AI answer.
See the AI answerBuyer question
diabetes and obesity management program with monthly subscription
Sugarfit was not mentioned in this AI answer.
See the AI answerWhat to fix first
The shortest path to better AI search presence
Readable turns missed buyer questions into pages AI can trust, clearer evidence buyers can verify, and comparison answers that make it easier for AI tools to recommend you.
Close the Blood Sugar Tracking gap before competitors keep winning the recommendation.: Buyers keep seeing competitors on Blood Sugar Tracking. Strengthen the proof and page coverage around it before this gap compounds.
Secure citations in buyer query responses for 'diabetes management with telemedicine' and 'affordable subscription diabetes care' by establishing Sugarfit as a primary Indian platform option alongside mfine/Practo—target responses that currently omit all three brands.
Create comparison landing pages for 'Sugarfit vs mfine' and 'Sugarfit vs Practo for telemedicine' to capture the inverse comparison intent; currently only forward comparisons exist, limiting bidirectional traffic.
Develop content positioning Sugarfit's AI-driven personalization and subscription pricing (₹500-2000 range) as citation sources for 'affordable diabetes + weight loss' and 'personalized metabolic health' queries where competitors currently dominate through generic feature mentions.
Sugarfit is completely absent from 'best diabetes management app with doctor consultation' and 'real-time glucose tracking with virtual appointments' queries where mfine and Practo are explicitly mentioned—these high-intent queries represent critical discovery gaps.
What you’ll see in the AI search review
Find the AI answers costing you buyers
In one review, we’ll show where Sugarfit is missing, which competitors AI is recommending instead, and the first pages or evidence updates most likely to help you show up.
The buyer questions where Sugarfit is left out.
The competitor claims AI is repeating instead.
The first fixes most likely to help Sugarfit show up.
Fix the buyer moments AI is missing
We’ll show you which AI answers are costing you buyers and what to publish first.
Bring this report to a short review with Readable. You will leave knowing the buyer questions, evidence gaps, and answer pages that matter most.
Improve my AI visibility